Systemic candidiasis in mice treated with prednisolone and amphotericin B. 2. Ultrastructure and evidence for fungal

Mycopathologia
|December 29, 1978
PubMed

Insights

Amphotericin B (AmB) causes ultrastructural damage to Candida albicans cells, including cell wall changes and organelle destruction. Toxic protein components were detected in AmB-treated fungal extracts, impacting mice treated with Actinomycin D.

Area of Science:

  • Mycology
  • Cell Biology
  • Pharmacology

Background:

  • Candida albicans is a common fungal pathogen.
  • Amphotericin B (AmB) is a key antifungal agent.
  • Prednisolone can modulate host response to infection.

Purpose of the Study:

  • To investigate the ultrastructural effects of Amphotericin B on Candida albicans cells.
  • To assess the toxicity of Amphotericin B-treated Candida albicans extracts.
  • To determine the influence of prednisolone on these effects.

Main Methods:

  • Transmission electron microscopy to observe cellular ultrastructure.
  • In vitro and in vivo treatment of Candida albicans with Amphotericin B.
  • Administration of fungal extracts and leachates to mice, with or without Actinomycin D.
  • Polyacrylamide gel electrophoresis to analyze toxic components.

Main Results:

  • Amphotericin B induced plasmolysis, vacuolation, and organelle destruction in Candida albicans.
  • Cell wall lamination was prominent in vivo, particularly with prednisolone co-treatment.
  • Somatic extracts and leachates from treated cells exhibited low-grade toxicity in mice.
  • Toxic components were identified as high molecular weight proteins.

Conclusions:

  • Amphotericin B causes significant cellular damage to Candida albicans.
  • Prednisolone may enhance the in vivo effects of Amphotericin B on fungal cell walls.
  • Fungal extracts from Amphotericin B treatment contain toxic, proteinaceous components.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...